Skip to main content
Top
Published in: Journal of Immigrant and Minority Health 3/2014

01-06-2014 | Original Paper

HPV Awareness and Vaccine Acceptability in Hispanic Women Living Along the US-Mexico Border

Authors: Jennifer Molokwu, Norma P. Fernandez, Charmaine Martin

Published in: Journal of Immigrant and Minority Health | Issue 3/2014

Login to get access

Abstract

Despite advances in prevention of cervical cancer in the US, women of Hispanic origin still bear an unequal burden in cervical cancer incidence, morbidity and mortality. Our objective was to determine the HPV vaccine knowledge and acceptability in a group of mostly Hispanic females. In this cross sectional survey, 62 % of participants heard of HPV; 34.9 % identified HPV as a cause of cervical cancer. 63 % of participants reported willingness to receive vaccine and 77 % were willing to vaccinate daughters. Those with previous abnormal PAPs were more likely to have heard of HPV and Vaccine. No other factors examined showed association with willingness to get vaccine or administer to daughters. Knowledge level remains low in this high risk population. Willingness to receive vaccine is high despite lack of access to care. Increased targeted community based education and vaccination programs may be useful in closing disparity in cervical cancer morbidity.
Literature
1.
go back to reference Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health. 2000;36(1):6–10.CrossRef Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health. 2000;36(1):6–10.CrossRef
2.
go back to reference Kahn JA, Hillard PA. Human papillomavirus and cervical cytology in adolescents. Adolesc Med Clin. 2004;15(2):301–321, ix. Kahn JA, Hillard PA. Human papillomavirus and cervical cytology in adolescents. Adolesc Med Clin. 2004;15(2):301–321, ix.
3.
go back to reference Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.PubMedCrossRef Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.PubMedCrossRef
4.
go back to reference Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995;33(8):2058–63.PubMedCentralPubMed Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995;33(8):2058–63.PubMedCentralPubMed
5.
go back to reference WHO/ICO Information Center on HPV and Cervical Cancer (HPV Information Center). Human papillomavirus and related cancers in the world. Summary Report 2010. www.who.int/hpvcentre. Accessed 11 Oct 2012. WHO/ICO Information Center on HPV and Cervical Cancer (HPV Information Center). Human papillomavirus and related cancers in the world. Summary Report 2010. www.​who.​int/​hpvcentre. Accessed 11 Oct 2012.
7.
go back to reference Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.PubMedCrossRef Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.PubMedCrossRef
8.
go back to reference Risser DR, Mokry B, Bowcock C, Miller EA, Williams MA, Magid R, Garcia R. Cervical Cancer in Texas, 2010. Austin, TX: Texas Cancer Registry, Texas Department of State Health Services; Cancer Prevention Research Institute of Texas; 2010. Risser DR, Mokry B, Bowcock C, Miller EA, Williams MA, Magid R, Garcia R. Cervical Cancer in Texas, 2010. Austin, TX: Texas Cancer Registry, Texas Department of State Health Services; Cancer Prevention Research Institute of Texas; 2010.
9.
go back to reference de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.PubMedCrossRef de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.PubMedCrossRef
10.
go back to reference Szarewski A, Poppe WA, Skinner SR, et al. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer. 2012;131(1):106–16.PubMedCrossRef Szarewski A, Poppe WA, Skinner SR, et al. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer. 2012;131(1):106–16.PubMedCrossRef
11.
go back to reference Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.PubMedCentralPubMedCrossRef Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.PubMedCentralPubMedCrossRef
12.
go back to reference Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–70.PubMedCrossRef Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–70.PubMedCrossRef
13.
go back to reference Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009;45(5):430–7.PubMedCrossRef Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009;45(5):430–7.PubMedCrossRef
14.
go back to reference Shen-Gunther J, Shank J, Ta V. Gardasil™ HPV vaccination HPV vaccination: surveillance of vaccine usage and adherence in a military population. Gynecol Oncol. 2011;123:272.PubMedCrossRef Shen-Gunther J, Shank J, Ta V. Gardasil™ HPV vaccination HPV vaccination: surveillance of vaccine usage and adherence in a military population. Gynecol Oncol. 2011;123:272.PubMedCrossRef
15.
go back to reference Manhart LE, Burgess-Hull AJ, Fleming CB, Bailey JA, Haggerty KP, Catalano RF. HPV vaccination among a community sample of young adult women. Vaccine. 2011;29(32):5238–44.PubMedCentralPubMedCrossRef Manhart LE, Burgess-Hull AJ, Fleming CB, Bailey JA, Haggerty KP, Catalano RF. HPV vaccination among a community sample of young adult women. Vaccine. 2011;29(32):5238–44.PubMedCentralPubMedCrossRef
16.
go back to reference (CDC) CfDCaP. National and state vaccination coverage among adolescents aged 13 through 17 years–United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(33):1117–23. (CDC) CfDCaP. National and state vaccination coverage among adolescents aged 13 through 17 years–United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(33):1117–23.
17.
go back to reference Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93.PubMedCrossRef Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93.PubMedCrossRef
18.
go back to reference Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8(3):188–94.PubMedCrossRef Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8(3):188–94.PubMedCrossRef
19.
go back to reference Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis. 2007;34(7):468–71.PubMed Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis. 2007;34(7):468–71.PubMed
20.
go back to reference Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58(7):1405–13.PubMedCrossRef Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58(7):1405–13.PubMedCrossRef
22.
go back to reference Kobetz E, Kornfeld J, Vanderpool RC, Finney Rutten LJ, Parekh N, O’Bryan G, et al. Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun. 2010;15(Suppl 3):22–9.PubMedCrossRef Kobetz E, Kornfeld J, Vanderpool RC, Finney Rutten LJ, Parekh N, O’Bryan G, et al. Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun. 2010;15(Suppl 3):22–9.PubMedCrossRef
23.
go back to reference Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108–15.PubMedCrossRef Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108–15.PubMedCrossRef
24.
go back to reference Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123(6):1439–45.PubMedCrossRef Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123(6):1439–45.PubMedCrossRef
25.
go back to reference Sanderson M, Coker AL, Eggleston KS, Fernandez ME, Arrastia CD, Fadden MK. HPV vaccine acceptance among Latina mothers by HPV status. J Womens Health (Larchmt). 2009;18(11):1793–9.CrossRef Sanderson M, Coker AL, Eggleston KS, Fernandez ME, Arrastia CD, Fadden MK. HPV vaccine acceptance among Latina mothers by HPV status. J Womens Health (Larchmt). 2009;18(11):1793–9.CrossRef
26.
go back to reference Waller PR, Crow C, Sands D, Becker H. Health related attitudes and health promoting behaviors: differences between health fair attenders and a community group. Am J Health Promot. 1988;3(1):17–23, 32. Waller PR, Crow C, Sands D, Becker H. Health related attitudes and health promoting behaviors: differences between health fair attenders and a community group. Am J Health Promot. 1988;3(1):17–23, 32.
Metadata
Title
HPV Awareness and Vaccine Acceptability in Hispanic Women Living Along the US-Mexico Border
Authors
Jennifer Molokwu
Norma P. Fernandez
Charmaine Martin
Publication date
01-06-2014
Publisher
Springer US
Published in
Journal of Immigrant and Minority Health / Issue 3/2014
Print ISSN: 1557-1912
Electronic ISSN: 1557-1920
DOI
https://doi.org/10.1007/s10903-013-9855-z

Other articles of this Issue 3/2014

Journal of Immigrant and Minority Health 3/2014 Go to the issue